SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,515,641 | -53.4% | 12,530,245 | +1.1% | 0.00% | – |
| Q2 2023 | $16,117,936 | -36.3% | 12,398,412 | -13.8% | 0.00% | -100.0% |
| Q1 2023 | $25,310,400 | -42.6% | 14,380,909 | +2.4% | 0.00% | 0.0% |
| Q4 2022 | $44,103,212 | -29.3% | 14,045,609 | +10.3% | 0.00% | -50.0% |
| Q3 2022 | $62,383,000 | +30.7% | 12,731,109 | +10.5% | 0.00% | +100.0% |
| Q2 2022 | $47,714,000 | -19.0% | 11,525,158 | +13.7% | 0.00% | 0.0% |
| Q1 2022 | $58,890,000 | -15.9% | 10,135,861 | +8.5% | 0.00% | -50.0% |
| Q4 2021 | $70,054,000 | -15.4% | 9,340,555 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $82,851,000 | -24.0% | 9,195,335 | +1.0% | 0.00% | -33.3% |
| Q2 2021 | $108,991,000 | -4.6% | 9,105,258 | -0.2% | 0.00% | 0.0% |
| Q1 2021 | $114,302,000 | -13.4% | 9,122,317 | +7.9% | 0.00% | -25.0% |
| Q4 2020 | $131,919,000 | +71.8% | 8,453,658 | +4.0% | 0.00% | +33.3% |
| Q3 2020 | $76,795,000 | +1.2% | 8,126,559 | -4.1% | 0.00% | 0.0% |
| Q2 2020 | $75,909,000 | +39.3% | 8,471,895 | -1.0% | 0.00% | +50.0% |
| Q1 2020 | $54,493,000 | -23.3% | 8,554,638 | +0.8% | 0.00% | 0.0% |
| Q4 2019 | $71,048,000 | -5.8% | 8,488,504 | +1.8% | 0.00% | -33.3% |
| Q3 2019 | $75,433,000 | -15.7% | 8,335,106 | +0.3% | 0.00% | 0.0% |
| Q2 2019 | $89,490,000 | +21.6% | 8,309,161 | +7.7% | 0.00% | 0.0% |
| Q1 2019 | $73,578,000 | -15.6% | 7,712,588 | +1.5% | 0.00% | -25.0% |
| Q4 2018 | $87,194,000 | -31.2% | 7,595,252 | +1.6% | 0.00% | -20.0% |
| Q3 2018 | $126,746,000 | +9.3% | 7,477,691 | -8.4% | 0.01% | 0.0% |
| Q2 2018 | $115,926,000 | -12.1% | 8,163,823 | +17.6% | 0.01% | -16.7% |
| Q1 2018 | $131,924,000 | +79.6% | 6,943,424 | +55.0% | 0.01% | +100.0% |
| Q4 2017 | $73,472,000 | +24.6% | 4,479,969 | +13.9% | 0.00% | 0.0% |
| Q3 2017 | $58,979,000 | +93.1% | 3,931,954 | +13.3% | 0.00% | +50.0% |
| Q2 2017 | $30,551,000 | +90.3% | 3,471,681 | +12.4% | 0.00% | +100.0% |
| Q1 2017 | $16,056,000 | +84.8% | 3,087,650 | +8.4% | 0.00% | – |
| Q4 2016 | $8,686,000 | -31.2% | 2,848,106 | +4.5% | 0.00% | -100.0% |
| Q3 2016 | $12,620,000 | -19.1% | 2,725,744 | +1.2% | 0.00% | 0.0% |
| Q2 2016 | $15,601,000 | +4.8% | 2,694,393 | +9.5% | 0.00% | 0.0% |
| Q1 2016 | $14,883,000 | -35.4% | 2,460,107 | -2.5% | 0.00% | -50.0% |
| Q4 2015 | $23,033,000 | +64.9% | 2,522,845 | +1.8% | 0.00% | +100.0% |
| Q3 2015 | $13,971,000 | -46.0% | 2,477,179 | +6.2% | 0.00% | -50.0% |
| Q2 2015 | $25,859,000 | -27.0% | 2,331,734 | +3.2% | 0.00% | 0.0% |
| Q1 2015 | $35,434,000 | +8.6% | 2,259,797 | +5.3% | 0.00% | 0.0% |
| Q4 2014 | $32,631,000 | +48.0% | 2,145,386 | +5.0% | 0.00% | 0.0% |
| Q3 2014 | $22,042,000 | -28.4% | 2,043,798 | +1.4% | 0.00% | 0.0% |
| Q2 2014 | $30,792,000 | -13.0% | 2,016,481 | +3.0% | 0.00% | -33.3% |
| Q1 2014 | $35,412,000 | +43.7% | 1,958,622 | +10.4% | 0.00% | +50.0% |
| Q4 2013 | $24,637,000 | +40.6% | 1,773,751 | +6.1% | 0.00% | 0.0% |
| Q3 2013 | $17,526,000 | +59.0% | 1,672,357 | +18.5% | 0.00% | +100.0% |
| Q2 2013 | $11,026,000 | – | 1,411,758 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |